Nanjing Vazyme Biotech Co., Ltd (SHA:688105)
China flag China · Delayed Price · Currency is CNY
19.89
-0.79 (-3.82%)
Nov 17, 2026, 3:00 PM CST

Nanjing Vazyme Biotech Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
1,5571,3781,3781,2863,5691,869
Revenue Growth
15.79%-0.00%7.15%-63.97%91.00%19.44%
Gross Profit
1,050920.21940.43771.12,1761,479
Operating Income
-61.49-111.66-112.85-271.53850.23729.91
Net Income
0.99-16.61-18.09-70.96594.25678.29
Earnings Per Share
0.00-0.03-0.04-0.141.151.44
EPS Growth
-----20.32%-19.04%

Revenue by Segment

Fiscal Year
FY 2025
Period EndingDec '25
Research and Experimental Development
1,170
Pharmaceutical Manufacturing
202.94
Total
1,373

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
2,7912,8542,6563,4813,2643,454
Total Debt
856.9842.44751.711,287458.1491.18
Net Cash (Debt)
1,9342,0121,9052,1942,8063,362
Net Cash Growth
4.00%5.62%-13.19%-21.81%-16.56%230.91%
Net Cash Per Share
2.953.734.054.285.417.13

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
272.06233.16-9.68152.99735.17616.8
Capital Expenditures
-29.98-47.39-74.9-232.9-962.86-261.96
Free Cash Flow
242.09185.77-84.58-79.91-227.69354.84
Free Cash Flow Growth
112.09%-----45.49%

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
67.47%66.78%68.25%59.96%60.98%79.13%
Operating Margin
-3.95%-8.10%-8.19%-21.12%23.82%39.06%
Pretax Margin
-1.34%-2.74%-4.23%-9.00%17.07%40.91%
Profit Margin
0.06%-1.21%-1.31%-5.52%16.65%36.30%
FCF Margin
15.55%13.48%-6.14%-6.21%-6.38%18.99%

Dividends

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Dividend Per Share
0.3850.3850.1390.0770.9620.300
Dividend Per Share Growth
261.12%177.69%80.10%-92.00%220.50%-
Dividend Yield
1.93%2.50%0.81%0.31%2.35%0.37%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
13111.40---35.7762.51
Forward PE
143.0074.6143.6848.0323.2157.10
P/FCF Ratio
43.6942.86---119.49
PS Ratio
6.805.786.409.965.9622.69